Corporation
AbCellera Biologics Inc.
- Meetings this Parliament
- 71
- With MPs
- 4
- Since Nov 2021
- 162
- Active registrations
- 1
Most recent reported meeting: Sep 29, 2026.
Lobbying by AbCellera Biologics Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Jun 9, 2026 Receives government funding
Filed by Carl Hansen, President
Lobbyists
- Andrew Booth · Chief Financial Officer
- Murray McCutcheon · VP Corporate Development
Institutions they may lobby: Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC)
What they're lobbying on (1)Hide details
- Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.
Registration 945748-366216-21. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Carl Hansen · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Wendy Hepburn · Deputy Director, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Doug Guzman · Chief Executive Officer, Public Services and Procurement Canada (PSPC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Hiba Kandalaft · Head of Regulatory Affairs, National Defence (DND)
- Paul Eagan · Medical Consultant, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Nadeen Abd El Aal · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Jean-Francois Courtois · Executive Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Braeden Caley · Deputy Chief of Staff, Prime Minister's Office (PMO)
- Yash Nanda · Senior Policy Advisor, Prime Minister's Office (PMO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Natasha Kim · Associate Deputy Minister, National Defence (DND)
- Scott Malcolm · Surgeon General, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Eagan · Medical Consultant, National Defence (DND)
- Hiba Kandalaft · Head of Regulatory Affairs, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Quinn Rinke · Regional Advisor, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Olivia Le Harivel De Gonneville · Officer, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Ryan Cotter · Legislative Assistant, House of Commons
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Inga Pusca · Principal Manager, Innovation, Science and Economic Development Canada (ISED)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
- Cynthia Case · Officer, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Razan Shahin · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Phillip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Stephanie Tanton · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Hiba Kandalaft · Head of Regulatory Affairs, National Defence (DND)
- Paul Eagan · Medical Consultant, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Mitch Davies · President, NRC, National Research Council (NRC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Eagan · Medical Consultant, National Defence (DND)
- Hiba Kandalaft · Head of Regulatory Affairs, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Natasha Kim · Associate Deputy Minister, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Quinn Rinke · Regional Advisor, National Defence (DND)
- Andrew Green · Director of Operations, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.